pharmaobservatory 0.1.6 → 0.1.8
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- checksums.yaml +4 -4
- data/README.md +348 -4
- data/docs/BiomarkerAlleleFrequenciesResponse.md +58 -0
- data/docs/BiomarkerAlleleFrequenciesRow.md +62 -0
- data/docs/BiomarkerAssayProvidersResponse.md +58 -0
- data/docs/BiomarkerAssayProvidersRow.md +72 -0
- data/docs/BiomarkerEvidenceByYearResponse.md +58 -0
- data/docs/BiomarkerEvidenceByYearRow.md +32 -0
- data/docs/BiomarkerTraversalStatusResponse.md +58 -0
- data/docs/BiomarkerTraversalStatusRow.md +36 -0
- data/docs/BiomarkersApi.md +320 -0
- data/docs/BrandCompaniesResponse.md +58 -0
- data/docs/BrandCompaniesRow.md +50 -0
- data/docs/BrandRevenueResponse.md +58 -0
- data/docs/BrandRevenueRow.md +60 -0
- data/docs/CatalystsResponse.md +58 -0
- data/docs/CatalystsRow.md +90 -0
- data/docs/CliaCertificatesResponse.md +58 -0
- data/docs/CliaCertificatesRow.md +80 -0
- data/docs/CompaniesApi.md +2656 -196
- data/docs/CompaniesRecordAttributes.md +3 -1
- data/docs/CompanyAssetsRow.md +5 -1
- data/docs/CompanyBiomarkerCapabilityResponse.md +58 -0
- data/docs/CompanyBiomarkerCapabilityRow.md +68 -0
- data/docs/CompanyFundingEventsRow.md +2 -0
- data/docs/CompanyProgramsRow.md +5 -1
- data/docs/CompanyRareDiseaseDeclarationsResponse.md +58 -0
- data/docs/CompanyRareDiseaseDeclarationsRow.md +52 -0
- data/docs/CompanyTrialGeographyResponse.md +58 -0
- data/docs/CompanyTrialGeographyRow.md +52 -0
- data/docs/CompanyTrialSitesResponse.md +58 -0
- data/docs/CompanyTrialSitesRow.md +52 -0
- data/docs/ConditionsApi.md +320 -0
- data/docs/CroFootprintResponse.md +58 -0
- data/docs/CroFootprintRow.md +34 -0
- data/docs/CroTrialsResponse.md +58 -0
- data/docs/CroTrialsRow.md +46 -0
- data/docs/DebarmentsResponse.md +58 -0
- data/docs/DebarmentsRow.md +44 -0
- data/docs/DrugApprovalsResponse.md +58 -0
- data/docs/DrugApprovalsRow.md +28 -0
- data/docs/DrugAspCodesResponse.md +58 -0
- data/docs/DrugAspCodesRow.md +28 -0
- data/docs/DrugBrandsResponse.md +58 -0
- data/docs/DrugBrandsRow.md +60 -0
- data/docs/DrugCombinationsResponse.md +58 -0
- data/docs/DrugCombinationsRow.md +32 -0
- data/docs/DrugDeclaredPatentsResponse.md +58 -0
- data/docs/DrugDeclaredPatentsRow.md +58 -0
- data/docs/DrugLabelSafetyResponse.md +58 -0
- data/docs/DrugLabelSafetyRow.md +32 -0
- data/docs/DrugMedicareSpendResponse.md +58 -0
- data/docs/DrugMedicareSpendRow.md +28 -0
- data/docs/DrugPatentCliffRow.md +3 -1
- data/docs/DrugPatentMentionsResponse.md +58 -0
- data/docs/DrugPatentMentionsRow.md +28 -0
- data/docs/DrugPatentOwnersResponse.md +58 -0
- data/docs/DrugPatentOwnersRow.md +42 -0
- data/docs/DrugPricingResponse.md +58 -0
- data/docs/DrugPricingRow.md +32 -0
- data/docs/DrugRecallsResponse.md +58 -0
- data/docs/DrugRecallsRow.md +34 -0
- data/docs/DrugRegulatoryResponse.md +58 -0
- data/docs/DrugRegulatoryRow.md +38 -0
- data/docs/DrugSitesResponse.md +58 -0
- data/docs/DrugSitesRow.md +28 -0
- data/docs/DrugTargetsResponse.md +58 -0
- data/docs/DrugTargetsRow.md +36 -0
- data/docs/DrugTrialConditionsResponse.md +58 -0
- data/docs/DrugTrialConditionsRow.md +30 -0
- data/docs/DrugTrialsResponse.md +58 -0
- data/docs/DrugTrialsRow.md +58 -0
- data/docs/DrugVariantsResponse.md +58 -0
- data/docs/DrugVariantsRow.md +38 -0
- data/docs/DrugsApi.md +2153 -0
- data/docs/DrugsRecord.md +38 -0
- data/docs/DrugsRecordAttributes.md +20 -0
- data/docs/DrugsResponse.md +58 -0
- data/docs/DrugsRow.md +82 -0
- data/docs/EnforcementEventsResponse.md +58 -0
- data/docs/EnforcementEventsRow.md +64 -0
- data/docs/GxpFacilitiesResponse.md +58 -0
- data/docs/GxpFacilitiesRow.md +174 -0
- data/docs/HospitalBedsYearlyResponse.md +58 -0
- data/docs/HospitalBedsYearlyRow.md +28 -0
- data/docs/HospitalFacilityChangesResponse.md +58 -0
- data/docs/HospitalFacilityChangesRow.md +30 -0
- data/docs/HospitalsApi.md +393 -0
- data/docs/HospitalsRecord.md +38 -0
- data/docs/HospitalsResponse.md +58 -0
- data/docs/HospitalsRow.md +40 -0
- data/docs/ImportRefusalsResponse.md +58 -0
- data/docs/ImportRefusalsRow.md +60 -0
- data/docs/InspectionFindingsResponse.md +58 -0
- data/docs/InspectionFindingsRow.md +48 -0
- data/docs/InspectionsResponse.md +58 -0
- data/docs/InspectionsRow.md +60 -0
- data/docs/InstitutionalQuarterTotalsResponse.md +58 -0
- data/docs/InstitutionalQuarterTotalsRow.md +58 -0
- data/docs/LegalEntitiesApi.md +2257 -177
- data/docs/LegalEntitiesRecordAttributes.md +8 -0
- data/docs/LegalEntitySecFilingsResponse.md +58 -0
- data/docs/LegalEntitySecFilingsRow.md +44 -0
- data/docs/OrgDisclosureTrendResponse.md +58 -0
- data/docs/OrgDisclosureTrendRow.md +62 -0
- data/docs/OrgRelationshipsRow.md +1 -1
- data/docs/OwnershipPercentagesResponse.md +58 -0
- data/docs/OwnershipPercentagesRow.md +74 -0
- data/docs/OwnershipSourceCoverageResponse.md +58 -0
- data/docs/OwnershipSourceCoverageRow.md +62 -0
- data/docs/PdufaDatesRow.md +1 -1
- data/docs/ProgramLicensingCandidatesResponse.md +58 -0
- data/docs/ProgramLicensingCandidatesRow.md +62 -0
- data/docs/ProgramsResponse.md +58 -0
- data/docs/ProgramsRow.md +46 -0
- data/docs/RareDiseaseGenesResponse.md +58 -0
- data/docs/RareDiseaseGenesRow.md +50 -0
- data/docs/RareDiseaseHierarchyResponse.md +58 -0
- data/docs/RareDiseaseHierarchyRow.md +40 -0
- data/docs/RareDiseaseInvestigatorCoverageResponse.md +58 -0
- data/docs/RareDiseaseInvestigatorCoverageRow.md +38 -0
- data/docs/RareDiseaseInvestigatorsResponse.md +58 -0
- data/docs/RareDiseaseInvestigatorsRow.md +56 -0
- data/docs/RareDiseaseMappingsResponse.md +58 -0
- data/docs/RareDiseaseMappingsRow.md +44 -0
- data/docs/RareDiseaseOrganizationsResponse.md +58 -0
- data/docs/RareDiseaseOrganizationsRow.md +60 -0
- data/docs/RareDiseasePrevalenceResponse.md +58 -0
- data/docs/RareDiseasePrevalenceRow.md +62 -0
- data/docs/RareDiseaseRarityEvidenceResponse.md +58 -0
- data/docs/RareDiseaseRarityEvidenceRow.md +36 -0
- data/docs/RareDiseaseRarityResponse.md +58 -0
- data/docs/RareDiseaseRarityRow.md +54 -0
- data/docs/RareDiseaseReplacementsResponse.md +58 -0
- data/docs/RareDiseaseReplacementsRow.md +40 -0
- data/docs/RareDiseaseSiteCoverageResponse.md +58 -0
- data/docs/RareDiseaseSiteCoverageRow.md +54 -0
- data/docs/RareDiseaseSponsorsResponse.md +58 -0
- data/docs/RareDiseaseSponsorsRow.md +82 -0
- data/docs/RareDiseaseTrialCoverageResponse.md +58 -0
- data/docs/RareDiseaseTrialCoverageRow.md +58 -0
- data/docs/RareDiseaseTrialSitesResponse.md +58 -0
- data/docs/RareDiseaseTrialSitesRow.md +52 -0
- data/docs/RareDiseaseTrialsResponse.md +58 -0
- data/docs/RareDiseaseTrialsRow.md +90 -0
- data/docs/RareDiseasesApi.md +1353 -0
- data/docs/RareDiseasesRecord.md +38 -0
- data/docs/RareDiseasesRecordAttributes.md +22 -0
- data/docs/RareDiseasesResponse.md +58 -0
- data/docs/RareDiseasesRow.md +68 -0
- data/docs/RecallsResponse.md +58 -0
- data/docs/RecallsRow.md +54 -0
- data/docs/RwdConductorDeliveryResponse.md +58 -0
- data/docs/RwdConductorDeliveryRow.md +74 -0
- data/docs/RwdConductorFootprintResponse.md +58 -0
- data/docs/RwdConductorFootprintRow.md +40 -0
- data/docs/RwdConductorStudiesResponse.md +58 -0
- data/docs/RwdConductorStudiesRow.md +42 -0
- data/docs/RwdConductorsApi.md +393 -0
- data/docs/RwdConductorsRecord.md +38 -0
- data/docs/RwdConductorsResponse.md +58 -0
- data/docs/RwdConductorsRow.md +72 -0
- data/docs/RwdCoverageResponse.md +58 -0
- data/docs/RwdCoverageRow.md +52 -0
- data/docs/RwdInstitutionsApi.md +153 -0
- data/docs/RwdInstitutionsRecord.md +38 -0
- data/docs/RwdInstitutionsResponse.md +58 -0
- data/docs/RwdInstitutionsRow.md +154 -0
- data/docs/RwdNetworksApi.md +153 -0
- data/docs/RwdNetworksRecord.md +38 -0
- data/docs/RwdNetworksResponse.md +58 -0
- data/docs/RwdNetworksRow.md +110 -0
- data/docs/RwdRegisterProvenanceResponse.md +58 -0
- data/docs/RwdRegisterProvenanceRow.md +74 -0
- data/docs/RwdRegistersApi.md +313 -0
- data/docs/RwdRegistersRecord.md +38 -0
- data/docs/RwdSourceAgeBandsResponse.md +58 -0
- data/docs/RwdSourceAgeBandsRow.md +40 -0
- data/docs/RwdSourceConditionsResponse.md +58 -0
- data/docs/RwdSourceConditionsRow.md +68 -0
- data/docs/RwdSourceEtlMappingsResponse.md +58 -0
- data/docs/RwdSourceEtlMappingsRow.md +44 -0
- data/docs/RwdSourceLinkagesResponse.md +58 -0
- data/docs/RwdSourceLinkagesRow.md +64 -0
- data/docs/RwdSourceTypesResponse.md +58 -0
- data/docs/RwdSourceTypesRow.md +34 -0
- data/docs/RwdSourceVocabulariesResponse.md +58 -0
- data/docs/RwdSourceVocabulariesRow.md +42 -0
- data/docs/RwdSourcesApi.md +713 -0
- data/docs/RwdSourcesRecord.md +38 -0
- data/docs/RwdSourcesResponse.md +58 -0
- data/docs/RwdSourcesRow.md +280 -0
- data/docs/RwdStudiesApi.md +553 -0
- data/docs/RwdStudiesRecord.md +38 -0
- data/docs/RwdStudiesResponse.md +58 -0
- data/docs/RwdStudiesRow.md +180 -0
- data/docs/RwdStudyConditionsResponse.md +58 -0
- data/docs/RwdStudyConditionsRow.md +54 -0
- data/docs/RwdStudyDataSourcesResponse.md +58 -0
- data/docs/RwdStudyDataSourcesRow.md +54 -0
- data/docs/RwdStudyDrugsResponse.md +58 -0
- data/docs/RwdStudyDrugsRow.md +50 -0
- data/docs/RwdStudyMilestonesResponse.md +58 -0
- data/docs/RwdStudyMilestonesRow.md +54 -0
- data/docs/RwdWithheldFieldsResponse.md +58 -0
- data/docs/RwdWithheldFieldsRow.md +36 -0
- data/docs/SbtiCrosscheckResponse.md +58 -0
- data/docs/SbtiCrosscheckRow.md +48 -0
- data/docs/SecPdufaDatesResponse.md +58 -0
- data/docs/SecPdufaDatesRow.md +64 -0
- data/docs/SponsorDeliveryResponse.md +58 -0
- data/docs/SponsorDeliveryRow.md +52 -0
- data/docs/SponsorPatentMentionsResponse.md +58 -0
- data/docs/SponsorPatentMentionsRow.md +42 -0
- data/docs/SponsorTrialConditionsResponse.md +58 -0
- data/docs/SponsorTrialConditionsRow.md +36 -0
- data/docs/SponsorTrialDrugsResponse.md +58 -0
- data/docs/SponsorTrialDrugsRow.md +34 -0
- data/docs/TrialChangesRow.md +5 -1
- data/docs/TrialsApi.md +80 -0
- data/docs/TrialsRow.md +9 -1
- data/docs/UnmatchedProductRevenueResponse.md +58 -0
- data/docs/UnmatchedProductRevenueRow.md +80 -0
- data/docs/UntitledLettersResponse.md +58 -0
- data/docs/UntitledLettersRow.md +44 -0
- data/docs/WarningLettersResponse.md +58 -0
- data/docs/WarningLettersRow.md +50 -0
- data/lib/pharmaobservatory/api/biomarkers_api.rb +336 -0
- data/lib/pharmaobservatory/api/companies_api.rb +3026 -296
- data/lib/pharmaobservatory/api/conditions_api.rb +336 -0
- data/lib/pharmaobservatory/api/drugs_api.rb +2261 -0
- data/lib/pharmaobservatory/api/hospitals_api.rb +413 -0
- data/lib/pharmaobservatory/api/legal_entities_api.rb +2376 -192
- data/lib/pharmaobservatory/api/rare_diseases_api.rb +1421 -0
- data/lib/pharmaobservatory/api/rwd_conductors_api.rb +413 -0
- data/lib/pharmaobservatory/api/rwd_institutions_api.rb +161 -0
- data/lib/pharmaobservatory/api/rwd_networks_api.rb +161 -0
- data/lib/pharmaobservatory/api/rwd_registers_api.rb +329 -0
- data/lib/pharmaobservatory/api/rwd_sources_api.rb +749 -0
- data/lib/pharmaobservatory/api/rwd_studies_api.rb +581 -0
- data/lib/pharmaobservatory/api/trials_api.rb +84 -0
- data/lib/pharmaobservatory/models/biomarker_allele_frequencies_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_allele_frequencies_row.rb +465 -0
- data/lib/pharmaobservatory/models/biomarker_assay_providers_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_assay_providers_row.rb +520 -0
- data/lib/pharmaobservatory/models/biomarker_evidence_by_year_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_evidence_by_year_row.rb +300 -0
- data/lib/pharmaobservatory/models/biomarker_traversal_status_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_traversal_status_row.rb +322 -0
- data/lib/pharmaobservatory/models/brand_companies_response.rb +478 -0
- data/lib/pharmaobservatory/models/brand_companies_row.rb +401 -0
- data/lib/pharmaobservatory/models/brand_revenue_response.rb +478 -0
- data/lib/pharmaobservatory/models/brand_revenue_row.rb +454 -0
- data/lib/pharmaobservatory/models/catalysts_response.rb +478 -0
- data/lib/pharmaobservatory/models/catalysts_row.rb +623 -0
- data/lib/pharmaobservatory/models/clia_certificates_response.rb +478 -0
- data/lib/pharmaobservatory/models/clia_certificates_row.rb +568 -0
- data/lib/pharmaobservatory/models/companies_record_attributes.rb +13 -4
- data/lib/pharmaobservatory/models/company_assets_row.rb +24 -2
- data/lib/pharmaobservatory/models/company_biomarker_capability_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_biomarker_capability_row.rb +498 -0
- data/lib/pharmaobservatory/models/company_funding_events_row.rb +12 -1
- data/lib/pharmaobservatory/models/company_programs_row.rb +24 -2
- data/lib/pharmaobservatory/models/company_rare_disease_declarations_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_rare_disease_declarations_row.rb +410 -0
- data/lib/pharmaobservatory/models/company_trial_geography_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_trial_geography_row.rb +410 -0
- data/lib/pharmaobservatory/models/company_trial_sites_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_trial_sites_row.rb +410 -0
- data/lib/pharmaobservatory/models/cro_footprint_response.rb +478 -0
- data/lib/pharmaobservatory/models/cro_footprint_row.rb +311 -0
- data/lib/pharmaobservatory/models/cro_trials_response.rb +478 -0
- data/lib/pharmaobservatory/models/cro_trials_row.rb +381 -0
- data/lib/pharmaobservatory/models/debarments_response.rb +478 -0
- data/lib/pharmaobservatory/models/debarments_row.rb +366 -0
- data/lib/pharmaobservatory/models/drug_approvals_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_approvals_row.rb +278 -0
- data/lib/pharmaobservatory/models/drug_asp_codes_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_asp_codes_row.rb +278 -0
- data/lib/pharmaobservatory/models/drug_brands_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_brands_row.rb +454 -0
- data/lib/pharmaobservatory/models/drug_combinations_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_combinations_row.rb +300 -0
- data/lib/pharmaobservatory/models/drug_declared_patents_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_declared_patents_row.rb +447 -0
- data/lib/pharmaobservatory/models/drug_label_safety_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_label_safety_row.rb +300 -0
- data/lib/pharmaobservatory/models/drug_medicare_spend_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_medicare_spend_row.rb +280 -0
- data/lib/pharmaobservatory/models/drug_patent_cliff_row.rb +13 -2
- data/lib/pharmaobservatory/models/drug_patent_mentions_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_patent_mentions_row.rb +278 -0
- data/lib/pharmaobservatory/models/drug_patent_owners_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_patent_owners_row.rb +357 -0
- data/lib/pharmaobservatory/models/drug_pricing_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_pricing_row.rb +300 -0
- data/lib/pharmaobservatory/models/drug_recalls_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_recalls_row.rb +311 -0
- data/lib/pharmaobservatory/models/drug_regulatory_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_regulatory_row.rb +333 -0
- data/lib/pharmaobservatory/models/drug_sites_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_sites_row.rb +278 -0
- data/lib/pharmaobservatory/models/drug_targets_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_targets_row.rb +324 -0
- data/lib/pharmaobservatory/models/drug_trial_conditions_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_trial_conditions_row.rb +289 -0
- data/lib/pharmaobservatory/models/drug_trials_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_trials_row.rb +445 -0
- data/lib/pharmaobservatory/models/drug_variants_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_variants_row.rb +333 -0
- data/lib/pharmaobservatory/models/drugs_record.rb +385 -0
- data/lib/pharmaobservatory/models/drugs_record_attributes.rb +229 -0
- data/lib/pharmaobservatory/models/drugs_response.rb +478 -0
- data/lib/pharmaobservatory/models/drugs_row.rb +581 -0
- data/lib/pharmaobservatory/models/enforcement_events_response.rb +478 -0
- data/lib/pharmaobservatory/models/enforcement_events_row.rb +476 -0
- data/lib/pharmaobservatory/models/gxp_facilities_response.rb +478 -0
- data/lib/pharmaobservatory/models/gxp_facilities_row.rb +1089 -0
- data/lib/pharmaobservatory/models/hospital_beds_yearly_response.rb +478 -0
- data/lib/pharmaobservatory/models/hospital_beds_yearly_row.rb +278 -0
- data/lib/pharmaobservatory/models/hospital_facility_changes_response.rb +478 -0
- data/lib/pharmaobservatory/models/hospital_facility_changes_row.rb +289 -0
- data/lib/pharmaobservatory/models/hospitals_record.rb +385 -0
- data/lib/pharmaobservatory/models/hospitals_response.rb +478 -0
- data/lib/pharmaobservatory/models/hospitals_row.rb +344 -0
- data/lib/pharmaobservatory/models/import_refusals_response.rb +478 -0
- data/lib/pharmaobservatory/models/import_refusals_row.rb +454 -0
- data/lib/pharmaobservatory/models/inspection_findings_response.rb +478 -0
- data/lib/pharmaobservatory/models/inspection_findings_row.rb +388 -0
- data/lib/pharmaobservatory/models/inspections_response.rb +478 -0
- data/lib/pharmaobservatory/models/inspections_row.rb +454 -0
- data/lib/pharmaobservatory/models/institutional_quarter_totals_response.rb +478 -0
- data/lib/pharmaobservatory/models/institutional_quarter_totals_row.rb +443 -0
- data/lib/pharmaobservatory/models/legal_entities_record_attributes.rb +37 -1
- data/lib/pharmaobservatory/models/legal_entity_sec_filings_response.rb +478 -0
- data/lib/pharmaobservatory/models/legal_entity_sec_filings_row.rb +370 -0
- data/lib/pharmaobservatory/models/org_disclosure_trend_response.rb +478 -0
- data/lib/pharmaobservatory/models/org_disclosure_trend_row.rb +465 -0
- data/lib/pharmaobservatory/models/org_relationships_row.rb +1 -1
- data/lib/pharmaobservatory/models/ownership_percentages_response.rb +478 -0
- data/lib/pharmaobservatory/models/ownership_percentages_row.rb +531 -0
- data/lib/pharmaobservatory/models/ownership_source_coverage_response.rb +478 -0
- data/lib/pharmaobservatory/models/ownership_source_coverage_row.rb +465 -0
- data/lib/pharmaobservatory/models/pdufa_dates_row.rb +1 -1
- data/lib/pharmaobservatory/models/program_licensing_candidates_response.rb +478 -0
- data/lib/pharmaobservatory/models/program_licensing_candidates_row.rb +467 -0
- data/lib/pharmaobservatory/models/programs_response.rb +478 -0
- data/lib/pharmaobservatory/models/programs_row.rb +377 -0
- data/lib/pharmaobservatory/models/rare_disease_genes_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_genes_row.rb +399 -0
- data/lib/pharmaobservatory/models/rare_disease_hierarchy_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_hierarchy_row.rb +344 -0
- data/lib/pharmaobservatory/models/rare_disease_investigator_coverage_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_investigator_coverage_row.rb +333 -0
- data/lib/pharmaobservatory/models/rare_disease_investigators_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_investigators_row.rb +436 -0
- data/lib/pharmaobservatory/models/rare_disease_mappings_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_mappings_row.rb +366 -0
- data/lib/pharmaobservatory/models/rare_disease_organizations_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_organizations_row.rb +454 -0
- data/lib/pharmaobservatory/models/rare_disease_prevalence_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_prevalence_row.rb +465 -0
- data/lib/pharmaobservatory/models/rare_disease_rarity_evidence_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_rarity_evidence_row.rb +322 -0
- data/lib/pharmaobservatory/models/rare_disease_rarity_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_rarity_row.rb +421 -0
- data/lib/pharmaobservatory/models/rare_disease_replacements_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_replacements_row.rb +344 -0
- data/lib/pharmaobservatory/models/rare_disease_site_coverage_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_site_coverage_row.rb +421 -0
- data/lib/pharmaobservatory/models/rare_disease_sponsors_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_sponsors_row.rb +575 -0
- data/lib/pharmaobservatory/models/rare_disease_trial_coverage_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_trial_coverage_row.rb +449 -0
- data/lib/pharmaobservatory/models/rare_disease_trial_sites_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_trial_sites_row.rb +412 -0
- data/lib/pharmaobservatory/models/rare_disease_trials_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_trials_row.rb +623 -0
- data/lib/pharmaobservatory/models/rare_diseases_record.rb +385 -0
- data/lib/pharmaobservatory/models/rare_diseases_record_attributes.rb +238 -0
- data/lib/pharmaobservatory/models/rare_diseases_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_diseases_row.rb +500 -0
- data/lib/pharmaobservatory/models/recalls_response.rb +478 -0
- data/lib/pharmaobservatory/models/recalls_row.rb +421 -0
- data/lib/pharmaobservatory/models/rwd_conductor_delivery_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductor_delivery_row.rb +537 -0
- data/lib/pharmaobservatory/models/rwd_conductor_footprint_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductor_footprint_row.rb +346 -0
- data/lib/pharmaobservatory/models/rwd_conductor_studies_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductor_studies_row.rb +355 -0
- data/lib/pharmaobservatory/models/rwd_conductors_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_conductors_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductors_row.rb +526 -0
- data/lib/pharmaobservatory/models/rwd_coverage_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_coverage_row.rb +410 -0
- data/lib/pharmaobservatory/models/rwd_institutions_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_institutions_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_institutions_row.rb +981 -0
- data/lib/pharmaobservatory/models/rwd_networks_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_networks_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_networks_row.rb +733 -0
- data/lib/pharmaobservatory/models/rwd_register_provenance_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_register_provenance_row.rb +531 -0
- data/lib/pharmaobservatory/models/rwd_registers_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_source_age_bands_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_source_age_bands_row.rb +344 -0
- data/lib/pharmaobservatory/models/rwd_source_conditions_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_source_conditions_row.rb +502 -0
- data/lib/pharmaobservatory/models/rwd_source_etl_mappings_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_source_etl_mappings_row.rb +366 -0
- data/lib/pharmaobservatory/models/rwd_source_linkages_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_source_linkages_row.rb +476 -0
- data/lib/pharmaobservatory/models/rwd_source_types_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_source_types_row.rb +311 -0
- data/lib/pharmaobservatory/models/rwd_source_vocabularies_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_source_vocabularies_row.rb +355 -0
- data/lib/pharmaobservatory/models/rwd_sources_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_sources_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_sources_row.rb +1674 -0
- data/lib/pharmaobservatory/models/rwd_studies_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_studies_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_studies_row.rb +1138 -0
- data/lib/pharmaobservatory/models/rwd_study_conditions_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_study_conditions_row.rb +421 -0
- data/lib/pharmaobservatory/models/rwd_study_data_sources_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_study_data_sources_row.rb +423 -0
- data/lib/pharmaobservatory/models/rwd_study_drugs_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_study_drugs_row.rb +401 -0
- data/lib/pharmaobservatory/models/rwd_study_milestones_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_study_milestones_row.rb +421 -0
- data/lib/pharmaobservatory/models/rwd_withheld_fields_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_withheld_fields_row.rb +322 -0
- data/lib/pharmaobservatory/models/sbti_crosscheck_response.rb +478 -0
- data/lib/pharmaobservatory/models/sbti_crosscheck_row.rb +388 -0
- data/lib/pharmaobservatory/models/sec_pdufa_dates_response.rb +478 -0
- data/lib/pharmaobservatory/models/sec_pdufa_dates_row.rb +476 -0
- data/lib/pharmaobservatory/models/sponsor_delivery_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_delivery_row.rb +410 -0
- data/lib/pharmaobservatory/models/sponsor_patent_mentions_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_patent_mentions_row.rb +355 -0
- data/lib/pharmaobservatory/models/sponsor_trial_conditions_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_trial_conditions_row.rb +322 -0
- data/lib/pharmaobservatory/models/sponsor_trial_drugs_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_trial_drugs_row.rb +311 -0
- data/lib/pharmaobservatory/models/trial_changes_row.rb +24 -2
- data/lib/pharmaobservatory/models/trials_row.rb +47 -3
- data/lib/pharmaobservatory/models/unmatched_product_revenue_response.rb +478 -0
- data/lib/pharmaobservatory/models/unmatched_product_revenue_row.rb +564 -0
- data/lib/pharmaobservatory/models/untitled_letters_response.rb +478 -0
- data/lib/pharmaobservatory/models/untitled_letters_row.rb +366 -0
- data/lib/pharmaobservatory/models/warning_letters_response.rb +478 -0
- data/lib/pharmaobservatory/models/warning_letters_row.rb +399 -0
- data/lib/pharmaobservatory/version.rb +1 -1
- data/lib/pharmaobservatory.rb +210 -0
- metadata +422 -2
|
@@ -5,6 +5,7 @@
|
|
|
5
5
|
| Name | Type | Description | Notes |
|
|
6
6
|
| ---- | ---- | ----------- | ----- |
|
|
7
7
|
| **company_funding_summary** | [**CompanyFundingSummaryRow**](CompanyFundingSummaryRow.md) | | [optional] |
|
|
8
|
+
| **company_trial_geography** | [**CompanyTrialGeographyRow**](CompanyTrialGeographyRow.md) | | [optional] |
|
|
8
9
|
|
|
9
10
|
## Example
|
|
10
11
|
|
|
@@ -12,7 +13,8 @@
|
|
|
12
13
|
require 'pharmaobservatory'
|
|
13
14
|
|
|
14
15
|
instance = PharmaObservatory::CompaniesRecordAttributes.new(
|
|
15
|
-
company_funding_summary: null
|
|
16
|
+
company_funding_summary: null,
|
|
17
|
+
company_trial_geography: null
|
|
16
18
|
)
|
|
17
19
|
```
|
|
18
20
|
|
data/docs/CompanyAssetsRow.md
CHANGED
|
@@ -12,7 +12,9 @@
|
|
|
12
12
|
| **sponsor_group_name** | **String** | Display name of the sponsor's group. | [optional] |
|
|
13
13
|
| **drug_id** | **String** | The drug key. | [optional] |
|
|
14
14
|
| **drug_name** | **String** | The drug's name. | [optional] |
|
|
15
|
-
| **max_phase** | **Integer** | Highest phase the sponsor reached on the drug: 0
|
|
15
|
+
| **max_phase** | **Integer** | Highest phase the sponsor reached on the drug on the 0 to 4 scale: 0 not reported, 1 through 4 for phase 1 through phase 4 (4 is marketed); a split phase folds up to its higher phase. | [optional] |
|
|
16
|
+
| **max_phase_label** | **String** | The furthest phase reached with the split phases kept: Early 1, Phase 1, Phase 1/2, Phase 2, Phase 2/3, Phase 3, Phase 4, or Not reported. max_phase is the same value folded onto 0 to 4 (a split phase counts as its higher phase). | [optional] |
|
|
17
|
+
| **max_phase_fine_rank** | **Integer** | The finest phase rank behind max_phase_label: 6 Phase 4, 5 Phase 3, 4 Phase 2/3, 3 Phase 2, 2 Phase 1/2, 1 Phase 1, 0 Early 1, -1 not reported. Sort on it to order programs by furthest phase with the split phases kept; max_phase is the same value folded onto 0 to 4. | [optional] |
|
|
16
18
|
| **n_trials** | **Integer** | Distinct trials this sponsor leads on the drug. Counted once per trial within the sponsor organization, so it is not additive across a company's organizations. | [optional] |
|
|
17
19
|
| **n_active** | **Integer** | Of those trials, the number recruiting, not yet recruiting, active or enrolling by invitation. | [optional] |
|
|
18
20
|
| **last_year** | **Integer** | Latest start year among those trials. | [optional] |
|
|
@@ -33,6 +35,8 @@ instance = PharmaObservatory::CompanyAssetsRow.new(
|
|
|
33
35
|
drug_id: null,
|
|
34
36
|
drug_name: null,
|
|
35
37
|
max_phase: null,
|
|
38
|
+
max_phase_label: null,
|
|
39
|
+
max_phase_fine_rank: null,
|
|
36
40
|
n_trials: null,
|
|
37
41
|
n_active: null,
|
|
38
42
|
last_year: null,
|
|
@@ -0,0 +1,58 @@
|
|
|
1
|
+
# PharmaObservatory::CompanyBiomarkerCapabilityResponse
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **dataset** | **String** | | |
|
|
8
|
+
| **grain** | **String** | | [optional] |
|
|
9
|
+
| **object_type** | **String** | | [optional] |
|
|
10
|
+
| **id** | **String** | | [optional] |
|
|
11
|
+
| **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
|
|
12
|
+
| **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
|
|
13
|
+
| **rows** | [**Array<CompanyBiomarkerCapabilityRow>**](CompanyBiomarkerCapabilityRow.md) | | |
|
|
14
|
+
| **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
|
|
15
|
+
| **next_cursor** | **String** | | [optional] |
|
|
16
|
+
| **sort** | **Array<String>** | | [optional] |
|
|
17
|
+
| **filters** | **Array<Hash<String, Object>>** | | [optional] |
|
|
18
|
+
| **group_by** | **Array<String>** | | [optional] |
|
|
19
|
+
| **measures** | **Array<String>** | | [optional] |
|
|
20
|
+
| **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
|
|
21
|
+
| **source_credit** | **String** | | [optional] |
|
|
22
|
+
| **withheld_tiers** | **Array<String>** | | [optional] |
|
|
23
|
+
| **withheld_columns** | **Array<String>** | | [optional] |
|
|
24
|
+
| **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
|
|
25
|
+
| **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
|
|
26
|
+
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
27
|
+
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
28
|
+
|
|
29
|
+
## Example
|
|
30
|
+
|
|
31
|
+
```ruby
|
|
32
|
+
require 'pharmaobservatory'
|
|
33
|
+
|
|
34
|
+
instance = PharmaObservatory::CompanyBiomarkerCapabilityResponse.new(
|
|
35
|
+
dataset: null,
|
|
36
|
+
grain: null,
|
|
37
|
+
object_type: null,
|
|
38
|
+
id: null,
|
|
39
|
+
scope: null,
|
|
40
|
+
columns: null,
|
|
41
|
+
rows: null,
|
|
42
|
+
total: null,
|
|
43
|
+
next_cursor: null,
|
|
44
|
+
sort: null,
|
|
45
|
+
filters: null,
|
|
46
|
+
group_by: null,
|
|
47
|
+
measures: null,
|
|
48
|
+
attribution: null,
|
|
49
|
+
source_credit: null,
|
|
50
|
+
withheld_tiers: null,
|
|
51
|
+
withheld_columns: null,
|
|
52
|
+
freshness: null,
|
|
53
|
+
build: null,
|
|
54
|
+
build_state: null,
|
|
55
|
+
restriction: null
|
|
56
|
+
)
|
|
57
|
+
```
|
|
58
|
+
|
|
@@ -0,0 +1,68 @@
|
|
|
1
|
+
# PharmaObservatory::CompanyBiomarkerCapabilityRow
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **biomarker_validation_id** | **String** | The evidence assertion id. | [optional] |
|
|
8
|
+
| **organization_name** | **String** | The organization's name as filed on the evidence. | [optional] |
|
|
9
|
+
| **organization_org_id** | **String** | Legal-entity level: the organization record of the organization. | [optional] |
|
|
10
|
+
| **organization_company_id** | **String** | Company level: the company the organization belongs to (null when unresolved). | [optional] |
|
|
11
|
+
| **organization_company_name** | **String** | Display name of the organization's company. | [optional] |
|
|
12
|
+
| **organization_group_id** | **String** | Group level: the organization's current ultimate parent company; a root company's group is itself. | [optional] |
|
|
13
|
+
| **organization_group_name** | **String** | Display name of the organization's group. | [optional] |
|
|
14
|
+
| **gene_symbol** | **String** | The gene's HGNC (Human Genome Organisation Gene Nomenclature Committee) symbol; null for evidence that names no gene. | [optional] |
|
|
15
|
+
| **biomarker_id** | **String** | The biomarker's id (a hash, not the route key). | [optional] |
|
|
16
|
+
| **biomarker_display_name** | **String** | The biomarker's display name. | [optional] |
|
|
17
|
+
| **biomarker_kind** | **String** | The kind of biomarker. | [optional] |
|
|
18
|
+
| **biomarker_identity_status** | **String** | How firmly the biomarker's identity is resolved. | [optional] |
|
|
19
|
+
| **organization_role** | **String** | The organization's role in the evidence (for example assay developer or testing laboratory). | [optional] |
|
|
20
|
+
| **organization_match_tier** | **String** | How the organization was matched to its record. | [optional] |
|
|
21
|
+
| **tier** | **Integer** | The evidence tier, higher for stronger kinds of evidence. A label of the kind of evidence, not a quality score. | [optional] |
|
|
22
|
+
| **tier_label** | **String** | The evidence tier in words. | [optional] |
|
|
23
|
+
| **evidence_type** | **String** | The kind of evidence (companion diagnostic authorization, trial endpoint, trial eligibility, trial specimen collection, trial text mention or ClinVar clinical testing). | [optional] |
|
|
24
|
+
| **evidence_count** | **Integer** | Assertions that share this biomarker, organization and role. | [optional] |
|
|
25
|
+
| **evidence_ref** | **String** | The reference of the evidence (a trial id, a device application number or a project id). | [optional] |
|
|
26
|
+
| **evidence_ref_kind** | **String** | What evidence_ref is. | [optional] |
|
|
27
|
+
| **trial_id** | **String** | The trial's registry id (NCT, National Clinical Trial, number) when the evidence is a trial. | [optional] |
|
|
28
|
+
| **citation_url** | **String** | A link to the evidence. | [optional] |
|
|
29
|
+
| **evidence_snippet** | **String** | A short excerpt of the evidence. | [optional] |
|
|
30
|
+
| **biomarker_role** | **String** | The role the biomarker plays in the evidence. | [optional] |
|
|
31
|
+
| **is_surrogate_endpoint_claim** | **Boolean** | Whether the evidence claims the biomarker as a surrogate endpoint. | [optional] |
|
|
32
|
+
| **clinvar_scv_count** | **Integer** | ClinVar submissions behind a ClinVar row. | [optional] |
|
|
33
|
+
|
|
34
|
+
## Example
|
|
35
|
+
|
|
36
|
+
```ruby
|
|
37
|
+
require 'pharmaobservatory'
|
|
38
|
+
|
|
39
|
+
instance = PharmaObservatory::CompanyBiomarkerCapabilityRow.new(
|
|
40
|
+
biomarker_validation_id: null,
|
|
41
|
+
organization_name: null,
|
|
42
|
+
organization_org_id: null,
|
|
43
|
+
organization_company_id: null,
|
|
44
|
+
organization_company_name: null,
|
|
45
|
+
organization_group_id: null,
|
|
46
|
+
organization_group_name: null,
|
|
47
|
+
gene_symbol: null,
|
|
48
|
+
biomarker_id: null,
|
|
49
|
+
biomarker_display_name: null,
|
|
50
|
+
biomarker_kind: null,
|
|
51
|
+
biomarker_identity_status: null,
|
|
52
|
+
organization_role: null,
|
|
53
|
+
organization_match_tier: null,
|
|
54
|
+
tier: null,
|
|
55
|
+
tier_label: null,
|
|
56
|
+
evidence_type: null,
|
|
57
|
+
evidence_count: null,
|
|
58
|
+
evidence_ref: null,
|
|
59
|
+
evidence_ref_kind: null,
|
|
60
|
+
trial_id: null,
|
|
61
|
+
citation_url: null,
|
|
62
|
+
evidence_snippet: null,
|
|
63
|
+
biomarker_role: null,
|
|
64
|
+
is_surrogate_endpoint_claim: null,
|
|
65
|
+
clinvar_scv_count: null
|
|
66
|
+
)
|
|
67
|
+
```
|
|
68
|
+
|
|
@@ -25,6 +25,7 @@
|
|
|
25
25
|
| **event_stage** | **String** | The lifecycle stage the event's date refers to (for example sold_to_date, funded, closed, registered, announced). | [optional] |
|
|
26
26
|
| **administering_ic** | **String** | The National Institutes of Health institute or center that administers the grant (for example CA for the National Cancer Institute); null for the other sources. | [optional] |
|
|
27
27
|
| **n_awards** | **Integer** | Grant applications folded into the event; 1 for the other sources. | [optional] |
|
|
28
|
+
| **is_biomedical** | **Boolean** | Whether the event is life-sciences capital: a grant is always true, a Regulation D offering follows the filer's self-declared industry group, and an extracted financing follows the filer's SIC code. Never null; a filer that cannot be classified is false. | [optional] |
|
|
28
29
|
| **cumulative_raised_usd** | **Float** | The running total of disclosed amounts over the company's own events up to and including this one, in date order; null where the event has no company. | [optional] |
|
|
29
30
|
| **source_url** | **String** | Link to the filing the event was read from, where the source has one. | [optional] |
|
|
30
31
|
|
|
@@ -55,6 +56,7 @@ instance = PharmaObservatory::CompanyFundingEventsRow.new(
|
|
|
55
56
|
event_stage: null,
|
|
56
57
|
administering_ic: null,
|
|
57
58
|
n_awards: null,
|
|
59
|
+
is_biomedical: null,
|
|
58
60
|
cumulative_raised_usd: null,
|
|
59
61
|
source_url: null
|
|
60
62
|
)
|
data/docs/CompanyProgramsRow.md
CHANGED
|
@@ -14,7 +14,9 @@
|
|
|
14
14
|
| **drug_name** | **String** | The drug's name. | [optional] |
|
|
15
15
|
| **condition_id** | **String** | The condition key, a MeSH (Medical Subject Headings) descriptor id (D followed by six to nine digits). | [optional] |
|
|
16
16
|
| **condition_name** | **String** | The condition's name. | [optional] |
|
|
17
|
-
| **max_phase** | **Integer** | Highest phase reached: 0
|
|
17
|
+
| **max_phase** | **Integer** | Highest phase reached on the 0 to 4 scale: 0 not reported, 1 through 4 for phase 1 through phase 4 (4 is marketed); a split phase folds up to its higher phase. | [optional] |
|
|
18
|
+
| **max_phase_label** | **String** | The furthest phase reached with the split phases kept: Early 1, Phase 1, Phase 1/2, Phase 2, Phase 2/3, Phase 3, Phase 4, or Not reported. max_phase is the same value folded onto 0 to 4 (a split phase counts as its higher phase). | [optional] |
|
|
19
|
+
| **max_phase_fine_rank** | **Integer** | The finest phase rank behind max_phase_label: 6 Phase 4, 5 Phase 3, 4 Phase 2/3, 3 Phase 2, 2 Phase 1/2, 1 Phase 1, 0 Early 1, -1 not reported. Sort on it to order programs by furthest phase with the split phases kept; max_phase is the same value folded onto 0 to 4. | [optional] |
|
|
18
20
|
| **n_trials** | **Integer** | Lead-sponsored trials in the program. | [optional] |
|
|
19
21
|
| **n_active** | **Integer** | Of those, trials in an active status. | [optional] |
|
|
20
22
|
| **last_year** | **Integer** | Latest trial start year. | [optional] |
|
|
@@ -39,6 +41,8 @@ instance = PharmaObservatory::CompanyProgramsRow.new(
|
|
|
39
41
|
condition_id: null,
|
|
40
42
|
condition_name: null,
|
|
41
43
|
max_phase: null,
|
|
44
|
+
max_phase_label: null,
|
|
45
|
+
max_phase_fine_rank: null,
|
|
42
46
|
n_trials: null,
|
|
43
47
|
n_active: null,
|
|
44
48
|
last_year: null,
|
|
@@ -0,0 +1,58 @@
|
|
|
1
|
+
# PharmaObservatory::CompanyRareDiseaseDeclarationsResponse
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **dataset** | **String** | | |
|
|
8
|
+
| **grain** | **String** | | [optional] |
|
|
9
|
+
| **object_type** | **String** | | [optional] |
|
|
10
|
+
| **id** | **String** | | [optional] |
|
|
11
|
+
| **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
|
|
12
|
+
| **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
|
|
13
|
+
| **rows** | [**Array<CompanyRareDiseaseDeclarationsRow>**](CompanyRareDiseaseDeclarationsRow.md) | | |
|
|
14
|
+
| **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
|
|
15
|
+
| **next_cursor** | **String** | | [optional] |
|
|
16
|
+
| **sort** | **Array<String>** | | [optional] |
|
|
17
|
+
| **filters** | **Array<Hash<String, Object>>** | | [optional] |
|
|
18
|
+
| **group_by** | **Array<String>** | | [optional] |
|
|
19
|
+
| **measures** | **Array<String>** | | [optional] |
|
|
20
|
+
| **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
|
|
21
|
+
| **source_credit** | **String** | | [optional] |
|
|
22
|
+
| **withheld_tiers** | **Array<String>** | | [optional] |
|
|
23
|
+
| **withheld_columns** | **Array<String>** | | [optional] |
|
|
24
|
+
| **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
|
|
25
|
+
| **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
|
|
26
|
+
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
27
|
+
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
28
|
+
|
|
29
|
+
## Example
|
|
30
|
+
|
|
31
|
+
```ruby
|
|
32
|
+
require 'pharmaobservatory'
|
|
33
|
+
|
|
34
|
+
instance = PharmaObservatory::CompanyRareDiseaseDeclarationsResponse.new(
|
|
35
|
+
dataset: null,
|
|
36
|
+
grain: null,
|
|
37
|
+
object_type: null,
|
|
38
|
+
id: null,
|
|
39
|
+
scope: null,
|
|
40
|
+
columns: null,
|
|
41
|
+
rows: null,
|
|
42
|
+
total: null,
|
|
43
|
+
next_cursor: null,
|
|
44
|
+
sort: null,
|
|
45
|
+
filters: null,
|
|
46
|
+
group_by: null,
|
|
47
|
+
measures: null,
|
|
48
|
+
attribution: null,
|
|
49
|
+
source_credit: null,
|
|
50
|
+
withheld_tiers: null,
|
|
51
|
+
withheld_columns: null,
|
|
52
|
+
freshness: null,
|
|
53
|
+
build: null,
|
|
54
|
+
build_state: null,
|
|
55
|
+
restriction: null
|
|
56
|
+
)
|
|
57
|
+
```
|
|
58
|
+
|
|
@@ -0,0 +1,52 @@
|
|
|
1
|
+
# PharmaObservatory::CompanyRareDiseaseDeclarationsRow
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **assertion_id** | **String** | The declaration assertion id. | [optional] |
|
|
8
|
+
| **organization_name** | **String** | The organization's name as the source filed it. | [optional] |
|
|
9
|
+
| **organization_org_id** | **String** | Legal-entity level: the organization record of the organization. | [optional] |
|
|
10
|
+
| **organization_company_id** | **String** | Company level: the company the organization belongs to (null when unresolved). | [optional] |
|
|
11
|
+
| **organization_company_name** | **String** | Display name of the organization's company. | [optional] |
|
|
12
|
+
| **organization_group_id** | **String** | Group level: the organization's current ultimate parent company; a root company's group is itself. | [optional] |
|
|
13
|
+
| **organization_group_name** | **String** | Display name of the organization's group. | [optional] |
|
|
14
|
+
| **declared_function** | **String** | The function the source states for the organization. | [optional] |
|
|
15
|
+
| **evidence_type** | **String** | The kind of evidence the source gives. | [optional] |
|
|
16
|
+
| **authority_class** | **String** | How authoritative the source is for the claim. | [optional] |
|
|
17
|
+
| **source_key** | **String** | The source the assertion comes from. | [optional] |
|
|
18
|
+
| **source_record_id** | **String** | The source's own record id. | [optional] |
|
|
19
|
+
| **source_url** | **String** | A link to the source record. | [optional] |
|
|
20
|
+
| **observed_at** | **Time** | When the assertion was observed (UTC). | [optional] |
|
|
21
|
+
| **last_verified_at** | **Time** | When the assertion was last verified (UTC). | [optional] |
|
|
22
|
+
| **confidence** | **Float** | The source's or the extraction's own confidence; null when none is stated. | [optional] |
|
|
23
|
+
| **license_name** | **String** | The licence of the source. | [optional] |
|
|
24
|
+
| **attribution** | **String** | The credit line for the source. | [optional] |
|
|
25
|
+
|
|
26
|
+
## Example
|
|
27
|
+
|
|
28
|
+
```ruby
|
|
29
|
+
require 'pharmaobservatory'
|
|
30
|
+
|
|
31
|
+
instance = PharmaObservatory::CompanyRareDiseaseDeclarationsRow.new(
|
|
32
|
+
assertion_id: null,
|
|
33
|
+
organization_name: null,
|
|
34
|
+
organization_org_id: null,
|
|
35
|
+
organization_company_id: null,
|
|
36
|
+
organization_company_name: null,
|
|
37
|
+
organization_group_id: null,
|
|
38
|
+
organization_group_name: null,
|
|
39
|
+
declared_function: null,
|
|
40
|
+
evidence_type: null,
|
|
41
|
+
authority_class: null,
|
|
42
|
+
source_key: null,
|
|
43
|
+
source_record_id: null,
|
|
44
|
+
source_url: null,
|
|
45
|
+
observed_at: null,
|
|
46
|
+
last_verified_at: null,
|
|
47
|
+
confidence: null,
|
|
48
|
+
license_name: null,
|
|
49
|
+
attribution: null
|
|
50
|
+
)
|
|
51
|
+
```
|
|
52
|
+
|
|
@@ -0,0 +1,58 @@
|
|
|
1
|
+
# PharmaObservatory::CompanyTrialGeographyResponse
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **dataset** | **String** | | |
|
|
8
|
+
| **grain** | **String** | | [optional] |
|
|
9
|
+
| **object_type** | **String** | | [optional] |
|
|
10
|
+
| **id** | **String** | | [optional] |
|
|
11
|
+
| **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
|
|
12
|
+
| **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
|
|
13
|
+
| **rows** | [**Array<CompanyTrialGeographyRow>**](CompanyTrialGeographyRow.md) | | |
|
|
14
|
+
| **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
|
|
15
|
+
| **next_cursor** | **String** | | [optional] |
|
|
16
|
+
| **sort** | **Array<String>** | | [optional] |
|
|
17
|
+
| **filters** | **Array<Hash<String, Object>>** | | [optional] |
|
|
18
|
+
| **group_by** | **Array<String>** | | [optional] |
|
|
19
|
+
| **measures** | **Array<String>** | | [optional] |
|
|
20
|
+
| **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
|
|
21
|
+
| **source_credit** | **String** | | [optional] |
|
|
22
|
+
| **withheld_tiers** | **Array<String>** | | [optional] |
|
|
23
|
+
| **withheld_columns** | **Array<String>** | | [optional] |
|
|
24
|
+
| **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
|
|
25
|
+
| **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
|
|
26
|
+
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
27
|
+
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
28
|
+
|
|
29
|
+
## Example
|
|
30
|
+
|
|
31
|
+
```ruby
|
|
32
|
+
require 'pharmaobservatory'
|
|
33
|
+
|
|
34
|
+
instance = PharmaObservatory::CompanyTrialGeographyResponse.new(
|
|
35
|
+
dataset: null,
|
|
36
|
+
grain: null,
|
|
37
|
+
object_type: null,
|
|
38
|
+
id: null,
|
|
39
|
+
scope: null,
|
|
40
|
+
columns: null,
|
|
41
|
+
rows: null,
|
|
42
|
+
total: null,
|
|
43
|
+
next_cursor: null,
|
|
44
|
+
sort: null,
|
|
45
|
+
filters: null,
|
|
46
|
+
group_by: null,
|
|
47
|
+
measures: null,
|
|
48
|
+
attribution: null,
|
|
49
|
+
source_credit: null,
|
|
50
|
+
withheld_tiers: null,
|
|
51
|
+
withheld_columns: null,
|
|
52
|
+
freshness: null,
|
|
53
|
+
build: null,
|
|
54
|
+
build_state: null,
|
|
55
|
+
restriction: null
|
|
56
|
+
)
|
|
57
|
+
```
|
|
58
|
+
|
|
@@ -0,0 +1,52 @@
|
|
|
1
|
+
# PharmaObservatory::CompanyTrialGeographyRow
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **company_id** | **String** | The company key (company:<key>). | [optional] |
|
|
8
|
+
| **company_name** | **String** | Display name of the company. | [optional] |
|
|
9
|
+
| **group_id** | **String** | Group level: the current ultimate parent company; a root company's group is itself. | [optional] |
|
|
10
|
+
| **group_name** | **String** | Display name of the group. | [optional] |
|
|
11
|
+
| **is_public_roster_root** | **Boolean** | True when the company is a public roster root: an organization the public Clinical Research Map lists. | [optional] |
|
|
12
|
+
| **roster_root_id** | **String** | The Clinical Research Map's organization key for this company: the group when it is a public roster root, else the company when it is one, else null. | [optional] |
|
|
13
|
+
| **roster_lead_trials** | **Integer** | For a public roster root, the lead-trial count the public organizations list sorts on; null for a company that is not one. | [optional] |
|
|
14
|
+
| **domicile_country** | **String** | ISO 3166-1 alpha-2 code of the company's legal-entity domicile; null when unknown. | [optional] |
|
|
15
|
+
| **site_country** | **String** | ISO 3166-1 alpha-2 code of the country holding the most of the company's own located led-trial sites; null when none resolves. | [optional] |
|
|
16
|
+
| **map_country** | **String** | The country the map places the company under: domicile_country, else site_country; null when neither is known. | [optional] |
|
|
17
|
+
| **map_country_basis** | **String** | Which signal map_country came from: domicile or trial_sites; null exactly when map_country is null. | [optional] |
|
|
18
|
+
| **n_located_sites** | **Integer** | The company's own located led-trial sites. | [optional] |
|
|
19
|
+
| **n_unlocated_sites** | **Integer** | The company's led-trial sites with no coordinate, which the map does not draw. | [optional] |
|
|
20
|
+
| **n_site_countries** | **Integer** | Distinct resolved countries among the company's located led-trial sites. | [optional] |
|
|
21
|
+
| **n_unresolved_sites** | **Integer** | Located led-trial sites whose country name resolves to no country code; they do not vote for site_country. | [optional] |
|
|
22
|
+
| **roster_map_country** | **String** | For a public roster root, the country the public Clinical Research Map shows the organization under, as published; null for a non-root. | [optional] |
|
|
23
|
+
| **roster_map_country_basis** | **String** | For a public roster root, which signal the public map's country came from: domicile or trial_sites; null for a non-root or an unknown country. | [optional] |
|
|
24
|
+
| **roster_n_located_sites** | **Integer** | For a public roster root, the located sites the public map draws the organization at (its group fold); null for a non-root. | [optional] |
|
|
25
|
+
|
|
26
|
+
## Example
|
|
27
|
+
|
|
28
|
+
```ruby
|
|
29
|
+
require 'pharmaobservatory'
|
|
30
|
+
|
|
31
|
+
instance = PharmaObservatory::CompanyTrialGeographyRow.new(
|
|
32
|
+
company_id: null,
|
|
33
|
+
company_name: null,
|
|
34
|
+
group_id: null,
|
|
35
|
+
group_name: null,
|
|
36
|
+
is_public_roster_root: null,
|
|
37
|
+
roster_root_id: null,
|
|
38
|
+
roster_lead_trials: null,
|
|
39
|
+
domicile_country: null,
|
|
40
|
+
site_country: null,
|
|
41
|
+
map_country: null,
|
|
42
|
+
map_country_basis: null,
|
|
43
|
+
n_located_sites: null,
|
|
44
|
+
n_unlocated_sites: null,
|
|
45
|
+
n_site_countries: null,
|
|
46
|
+
n_unresolved_sites: null,
|
|
47
|
+
roster_map_country: null,
|
|
48
|
+
roster_map_country_basis: null,
|
|
49
|
+
roster_n_located_sites: null
|
|
50
|
+
)
|
|
51
|
+
```
|
|
52
|
+
|
|
@@ -0,0 +1,58 @@
|
|
|
1
|
+
# PharmaObservatory::CompanyTrialSitesResponse
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **dataset** | **String** | | |
|
|
8
|
+
| **grain** | **String** | | [optional] |
|
|
9
|
+
| **object_type** | **String** | | [optional] |
|
|
10
|
+
| **id** | **String** | | [optional] |
|
|
11
|
+
| **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
|
|
12
|
+
| **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
|
|
13
|
+
| **rows** | [**Array<CompanyTrialSitesRow>**](CompanyTrialSitesRow.md) | | |
|
|
14
|
+
| **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
|
|
15
|
+
| **next_cursor** | **String** | | [optional] |
|
|
16
|
+
| **sort** | **Array<String>** | | [optional] |
|
|
17
|
+
| **filters** | **Array<Hash<String, Object>>** | | [optional] |
|
|
18
|
+
| **group_by** | **Array<String>** | | [optional] |
|
|
19
|
+
| **measures** | **Array<String>** | | [optional] |
|
|
20
|
+
| **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
|
|
21
|
+
| **source_credit** | **String** | | [optional] |
|
|
22
|
+
| **withheld_tiers** | **Array<String>** | | [optional] |
|
|
23
|
+
| **withheld_columns** | **Array<String>** | | [optional] |
|
|
24
|
+
| **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
|
|
25
|
+
| **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
|
|
26
|
+
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
27
|
+
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
28
|
+
|
|
29
|
+
## Example
|
|
30
|
+
|
|
31
|
+
```ruby
|
|
32
|
+
require 'pharmaobservatory'
|
|
33
|
+
|
|
34
|
+
instance = PharmaObservatory::CompanyTrialSitesResponse.new(
|
|
35
|
+
dataset: null,
|
|
36
|
+
grain: null,
|
|
37
|
+
object_type: null,
|
|
38
|
+
id: null,
|
|
39
|
+
scope: null,
|
|
40
|
+
columns: null,
|
|
41
|
+
rows: null,
|
|
42
|
+
total: null,
|
|
43
|
+
next_cursor: null,
|
|
44
|
+
sort: null,
|
|
45
|
+
filters: null,
|
|
46
|
+
group_by: null,
|
|
47
|
+
measures: null,
|
|
48
|
+
attribution: null,
|
|
49
|
+
source_credit: null,
|
|
50
|
+
withheld_tiers: null,
|
|
51
|
+
withheld_columns: null,
|
|
52
|
+
freshness: null,
|
|
53
|
+
build: null,
|
|
54
|
+
build_state: null,
|
|
55
|
+
restriction: null
|
|
56
|
+
)
|
|
57
|
+
```
|
|
58
|
+
|
|
@@ -0,0 +1,52 @@
|
|
|
1
|
+
# PharmaObservatory::CompanyTrialSitesRow
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **company_id** | **String** | The company key (company:<key>) of the lead sponsor. | [optional] |
|
|
8
|
+
| **company_name** | **String** | Display name of the company. | [optional] |
|
|
9
|
+
| **group_id** | **String** | Group level: the current ultimate parent company; a root company's group is itself. | [optional] |
|
|
10
|
+
| **group_name** | **String** | Display name of the group. | [optional] |
|
|
11
|
+
| **roster_root_id** | **String** | The Clinical Research Map's organization key for these rows: the group when it is a public roster root, else the company when it is one, else null. | [optional] |
|
|
12
|
+
| **site_id** | **String** | The site key: one facility spelling from the registry; the id the site page address carries. | [optional] |
|
|
13
|
+
| **facility_name** | **String** | The facility name as filed in the registry. | [optional] |
|
|
14
|
+
| **city** | **String** | City as filed. | [optional] |
|
|
15
|
+
| **state** | **String** | State or province as filed. | [optional] |
|
|
16
|
+
| **country** | **String** | Country name as filed. | [optional] |
|
|
17
|
+
| **site_country_code** | **String** | ISO 3166-1 alpha-2 code of the site's country, from the registry's country name; null when the name resolves to no country. | [optional] |
|
|
18
|
+
| **latitude** | **Float** | Latitude of the finest coordinate the site record has. | [optional] |
|
|
19
|
+
| **longitude** | **Float** | Longitude of the finest coordinate the site record has. | [optional] |
|
|
20
|
+
| **geo_precision** | **String** | How finely the coordinate places the site (city, postal and so on). | [optional] |
|
|
21
|
+
| **coord_source** | **String** | The source of the coordinate: aact (the registry's own), geonames (GeoNames) or als (Amazon Location Service). | [optional] |
|
|
22
|
+
| **n_trials** | **Integer** | Distinct trials the company leads that list the site. | [optional] |
|
|
23
|
+
| **site_rank** | **Integer** | 1 is the company's busiest located site (most led trials, then site key); dense per company. | [optional] |
|
|
24
|
+
| **n_sites** | **Integer** | The company's located site count, repeated on each of its rows. | [optional] |
|
|
25
|
+
|
|
26
|
+
## Example
|
|
27
|
+
|
|
28
|
+
```ruby
|
|
29
|
+
require 'pharmaobservatory'
|
|
30
|
+
|
|
31
|
+
instance = PharmaObservatory::CompanyTrialSitesRow.new(
|
|
32
|
+
company_id: null,
|
|
33
|
+
company_name: null,
|
|
34
|
+
group_id: null,
|
|
35
|
+
group_name: null,
|
|
36
|
+
roster_root_id: null,
|
|
37
|
+
site_id: null,
|
|
38
|
+
facility_name: null,
|
|
39
|
+
city: null,
|
|
40
|
+
state: null,
|
|
41
|
+
country: null,
|
|
42
|
+
site_country_code: null,
|
|
43
|
+
latitude: null,
|
|
44
|
+
longitude: null,
|
|
45
|
+
geo_precision: null,
|
|
46
|
+
coord_source: null,
|
|
47
|
+
n_trials: null,
|
|
48
|
+
site_rank: null,
|
|
49
|
+
n_sites: null
|
|
50
|
+
)
|
|
51
|
+
```
|
|
52
|
+
|